Baker & McKenzie Advises CureVac GmbH on Equity Investment by Bill & Melinda Gates Foundation
Baker & McKenzie advised CureVac GmbH on the Equity investment agreement with the Bill & Melinda Gates Foundation. The Foundation will invest 46 million euros (52 million dollars) in CureVac. In addition the Foundation will fund various programs for the development of vaccines.